Pathology
launch of X
market introduction of X
cost-effective device
global market of
successful market launch
disruptive concept of X
clinical expertise
clinical testing
patients
specific answers
cost-effective diagnosis
specific diagnostic assay
powerful device
Empowering diagnostics
global population
successful outcome of preliminary clinical tests
specific causes of inflammatory conditions
invasive test
inexpensive test
healthcare system
group of inflammatory
disease monitoring
world population
demonstrated diagnostic capability
spiral of repeated tests
new era of healthcare
product
specialist consultations
non-specialized personnel
need of reliable
major role
prevention
treatment
steps
limited resources
edge technical
standalone platform
enormous potential
race
advanced stage of development
feasibility study
financial aspects
related pathologies
developing Countries
synergy
timely fashion
business plan
growth
regulatory approval
sector
mission